Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

RBC Capital Downgrades 89bio to Sector Perform, Announces $15 Price Target

Author: Benzinga Newsdesk | January 12, 2024 08:16am
RBC Capital analyst Brian Abrahams downgrades 89bio (NASDAQ:ETNB) from Outperform to Sector Perform and announces $15 price target.

Posted In: ETNB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist